LeadStory

CNBC

AstraZeneca reportedly looks to move its listing across the Atlantic

CNBC · Current
CNBC
CNBC
Current

The Times reports that AstraZeneca, the U.K.'s most valuable public company, is looking to move its listing from London to the U.S.

BreakdownGenerated by LeadStory AI
  • AstraZeneca is reportedly considering moving its listing from London to the US.
  • CEO Pascal Soriot is said to be driving the potential move. 11s
  • AstraZeneca is the UK's most valuable public company, making up a significant portion of the FTSE 100. 17s
  • Key factors include valuation differences, tax regimes, and regulatory challenges in the UK. 1m 16s
  • The company is reportedly frustrated with UK restrictions on new medicine approvals. 1m 57s
Business